FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Inhibitor topics
Atherosclerosis
Computer Program
Circulation
Fluidically
Hypertension
Nucleic Acid
Oxidative Stress
Pyrrolidine
Hepatitis C
Hepatitis C Virus
Methyl Ester
Crystallin
Antagonist
Immunogenic
Polypeptide

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Inhibitor patents



      
           
This page is updated frequently with new Inhibitor-related patent applications. Subscribe to the Inhibitor RSS feed to automatically get the update: related Inhibitor RSS feeds. RSS updates for this page: Inhibitor RSS RSS


Date/App# patent app List of recent Inhibitor-related patents
07/24/14
20140208460
 Phacosporacea resistant soybean plants patent thumbnailnew patent Phacosporacea resistant soybean plants
The present invention relates to a method of increasing resistance against fungal pathogens of the family phacosporaceae in transgenic plants and/or plant cells. In these plants, the ethylene signaling pathway and/or activity of the ethylene signaling compounds is changed.
07/24/14
20140206889
 Novel mangromicin compound and production method therefor patent thumbnailnew patent Novel mangromicin compound and production method therefor
The present invention is based on the discovery of a microbe that produces an anti-trypanosomal drug having a novel skeleton. Specifically, this invention provides: a compound indicated by formula (i) having a trypanosomal inhibitory activity; an analog thereof; a production method therefor; and a lechevalieria sp.
07/24/14
20140206874
 Crystal form i of salt of a dipeptidyl peptidase-iv inhibitor and preparation method and use same patent thumbnailnew patent Crystal form i of salt of a dipeptidyl peptidase-iv inhibitor and preparation method and use same
The present invention relates to the crystal form i of salt of a dipeptidyl peptidase-iv inhibitor, and the preparation method and use thereof. In particular, it relates to the crystal form i of dihydrochloride salt of the compound (r)-2-[[7-(3-aminopiperidin-1-yl)-3,5-dimethyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-1-yl]methyl]benzonitrile represented by formula (1), which is a dipeptidyl peptidase-iv inhibitor, and the preparation method and use thereof.
07/24/14
20140206865
 Human adam-10 inhibitors patent thumbnailnew patent Human adam-10 inhibitors
The present invention provides compounds useful for inhibiting the adam-10 protein, with selectivity versus mmp-1. Such compounds are useful in the in vitro study of the role of adam-10 (and its inhibition) in biological processes.
07/24/14
20140206859
 Process for the preparation of compounds useful as inhibitors of sglt-2 patent thumbnailnew patent Process for the preparation of compounds useful as inhibitors of sglt-2
The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (sglt) being present in the intestine or kidney.. .
07/24/14
20140206858
 Process for the preparation of compounds useful as inhibitors of sglt-2 patent thumbnailnew patent Process for the preparation of compounds useful as inhibitors of sglt-2
The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (sglt) being present in the intestine or kidney.. .
07/24/14
20140206844
 Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material patent thumbnailnew patent Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
Described is a method for isolating multiple blood products from a single starting material. Isolation of multiple blood products from a single starting material maximizes the efficiency of blood product isolation.
07/24/14
20140206836
 Novel n- and c-terminal substituted antagonistic analogs of gh-rh patent thumbnailnew patent Novel n- and c-terminal substituted antagonistic analogs of gh-rh
There is provided a novel series of synthetic analogs of hgh-rh(1-29)nh2 (seq id no: 1) and hgh-rh(1-30)nh2. Of particular interest are those carrying phac, n-me-aib, dca, ac-ada, fer, ac-amc, me-nh-sub, phac-ada, ac-ada-d-phe, ac-ada-phe, dca-ada, dca-amc, nac-ada, ada-ada, or ch3—(ch2)10—co-ada, at the n-terminus and β-ala, amc, apa, ada, ae2a, ae4p, ε-lys(α-nh2), agm, lys(oct) or ahx, at the c-terminus.
07/24/14
20140206823
 Method for reducing the halogen content of a polymer patent thumbnailnew patent Method for reducing the halogen content of a polymer
The invention relates to a method for reducing the halogen content of a polymer, characterized in that the polymer is reacted with a polymerization inhibitor; and especially to a method wherein said polymer is a polymerization product of an atrp process.. .
07/24/14
20140206770
 Androgen receptor-dependent gene expression control patent thumbnailnew patent Androgen receptor-dependent gene expression control
Disclosed is the use of at least one amine oxidase inhibitor for modulating the activity of the lysine-specific demethylase (lsd1) in a mammal and to pharmaceutical compositions for controlling the androgen receptor-dependent gene expression, comprising an effective dose of at least one amine oxidase inhibitor suitable for modulating the activity of the lysine-specific demethylase (lsd1) in a mammal.. .
07/24/14
20140206760
new patent Macrocyclic urea and sulfamide derivatives as inhibitors of tafia
The invention relates to compounds of the formula (i) which are inhibitors of activated thrombin-activable fibrinolysis inhibitor. The compounds of the formula i are suitable for producing medicaments for prophylaxis, secondary prevention and treatment of one or more disorders associated with thromboses, embolisms, hypercoaguability or fibrotic changes..
07/24/14
20140206757
new patent Treatment of cancer
This disclosure provides agents, compositions and methods of treating cancer by inhibiting histone lysine specific demethylase 1 (lsd1) and/or and a histone lysine specific demethylase 2 (lsd2). Agents and compositions comprise statins and/or inhibitors of lsd1/2..
07/24/14
20140206738
new patent Lipase inhibitors
Is useful in the treatment and prevention of a disorder such as cachexia, stroke, atherosclerosis, coronary artery disease, and diabetes and pharmaceutical compositions of the same. Also, a method of screening for lipase inhibitors using a compound of formula (i) and determining its lipase inhibitory activity.
07/24/14
20140206722
new patent Methods of use of phenoxypropylamine compounds to treat depression
Disclosed herein are compositions and methods for treating depression using compositions comprising a compound of formula i. Disclosed herein are compositions and methods for treating depression using compositions comprising phenoxypropylamine compounds and derivatives having selective affinity for and antagonistic activity against the 5-ht1a receptor, as well as 5-ht reuptake inhibitory activity.
07/24/14
20140206715
new patent Preparation and use of compounds as protease inhibitors
And r, r1, r2, r3, r4, r5, r6, r6, r7 and r7′ are as defined in the specification; pharmaceutical compositions comprising the compounds of formula i and the method of inhibiting aspartyl protease, and in particular, the methods of treating cardiovascular diseases, cognitive and neurodegenerative diseases.. .
07/24/14
20140206713
new patent Benzoquinoline inhibitors of vesicular monoamine transporter 2
The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (vmat2), pharmaceutical compositions thereof, and methods of use thereof.. .
07/24/14
20140206712
new patent Benzoquinoline inhibitors of vesicular monoamine transporter 2
The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (vmat2), pharmaceutical compositions thereof, and methods of use thereof.. .
07/24/14
20140206706
new patent Five-membered heterocycles useful as serine protease inhibitors
Or a stereoisomer or pharmaceutically acceptable salt or solvate form thereof, wherein the variables a, l, z, r3, r4, r6, r11, x1, x2, and x3 are as defined herein. The compounds of formula (i) are useful as selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; for example thrombin, factor xa, factor xia, factor ixa, factor viia and/or plasma kallikrein.
07/24/14
20140206703
new patent Thieno [2, 3-d] pyrimidine derivatives and their use to treat arrhythmia
The present invention relates to thienopyrimidine compounds which are potassium channel inhibitors. Pharmaceutical compositions comprising the compounds and their use in the treatment of arrhythmia are also described..
07/24/14
20140206693
new patent Compositions and methods for treating colon cancer
Certain embodiments are directed to methods of treating a pathophysiological state or symptoms thereof resulting from aldose reductase-mediated signaling in a cytotoxic pathway using an aldose reductase specific inhibitor.. .
07/24/14
20140206692
new patent Oral formulations of kinase inhibitors
The invention is directed to formulations of bioactive compounds of limited water solubility, inhibitors of focal adhesion kinase (fak) of the 2,4-diaminopyridine class, adapted for oral administration to patients. The formulations are self-emulsifying in the gastrointestinal tract of the patients, providing enhanced absorption and bioavailability of the bioactive compounds as dispersions or emulsions in an oil base.
07/24/14
20140206691
new patent Cyclic protein tyrosine kinase inhibitors
Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.. .
07/24/14
20140206688
new patent Amino quinazolines as kinase inhibitors
Disclosed are compounds having the formula (formula i)): wherein r1, r2, r3 and z are as defined herein, and methods of making and using the same.. .
07/24/14
20140206686
new patent Phthalazinones and isoquinolinones as rock inhibitors
Or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective rock inhibitors.
07/24/14
20140206685
new patent Heterocyclic kinase inhibitors
The present invention provides heterocyclic compounds for use as kinase inhibitors and in other applications. Also provided are pharmaceutical compositions and methods of treatments of diseases and conditions associated with p13 kinase activity..
07/24/14
20140206683
new patent Macrocyclic lrrk2 kinase inhibitors
The present invention relates to novel macrocylic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of lrrk2 (leucine-rich repeat kinase 2). Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicine or diagnostic agent, in particular for the treatment and/or diagnosis of diseases characterized by lrrk2 kinase activity such as neurological disorders including parkinson's disease and alzheimer's disease..
07/24/14
20140206682
new patent Compounds and compositions as pdgfr kinase inhibitors
The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of pdgfr (pdgfrα, pdgfrβ) kinases or c-kit and pdgfr (pdgfrα, pdgfrβ) kinases..
07/24/14
20140206681
new patent Btk inhibitors
Or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of btk inhibitor compounds in the treatment of btk mediated disorders..
07/24/14
20140206679
new patent Heterocyclic pyridone compound, and intermediate, preparation method and use thereof
The present invention relates to a heterocyclic pyridone compound represented by general formula (i), where the heterocyclic pyridone compound is used as a tyrosine kinase inhibitor, and particularly a c-met inhibitor. The present invention also relates to intermediates for preparing heterocyclic pyridone compound and a preparation method.
07/24/14
20140206678
new patent Inhibitors of mtor kinase as anti -viral agent
The present invention provides methods for treating or preventing viral infections using modulators of host cell enzymes relating to mtor. The invention also provides methods for treating or preventing viral infections using modulators of host cell enzymes relating to mtor and modulators of the unfolded protein response..
07/24/14
20140206675
new patent Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds formula (i): (i) and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of r1, r2, r3, r4, r5, r9, ring a, ring b, m, n, p, -l1-, l2-, and l3- is selected independently and as defined herein. The novel iminothiadiazine dioxide compounds of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as bace inhibitors and/or for the treatment and prevention of various pathologies related to β-amyloid (aβ) production.
07/24/14
20140206671
new patent Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
The present invention relates to compounds useful as inhibitors of protein kinases, particularly of jak family kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders..
07/24/14
20140206670
new patent Combinations comprising alpha-2-delta ligands
The instant invention relates to a combination, particularly a synergistic combination, of an alpha-2-delta ligand and a dual serotonin-noradrenaline re-uptake inhibitor (dsnri) or one or both of a selective serotonin re-uptake inhibitor (ssri) and a selective noradrenaline re-uptake inhibitor (snri), and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof and their use in the treatment of pain, particularly neuropathic pain.. .
07/24/14
20140206667
new patent Methods and compositions for treating schizophrenia
The invention relates to methods and compositions for treating schizophrenia or bipolar disorder (in particular, mania) by using a combination of a synaptic vesicle protein 2a (sv2a) inhibitor and an antipsychotic or their pharmaceutically acceptable salts, hydrates, solvates, polymorphs thereof. In some embodiments, the methods and the compositions are for treating one or more positive and/or negative symptoms, as well as cognitive impairment, associated with schizophrenia or bipolar disorder (in particular, mania)..
07/24/14
20140206666
new patent Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
Pharmaceutical compositions of the invention comprise sulfamoylbenzamide derivative useful as pregenomic rna encapsidation inhibitors, useful for the treatment of hepatitis b virus (hbv) infection.. .
07/24/14
20140206665
new patent Selective glycosidase inhibitors and uses thereof
The invention is directed to compounds for selectively inhibiting glycosidases, uses of the compounds and pharmaceutical compositions including the compounds, and methods of treating diseases and disorders related to deficiency or overexpression of o-glcnacase, and/or accumulation or deficiency of o-glcnac.. .
07/24/14
20140206662
new patent Imidazopyridine compounds
And their pharmaceutically acceptable salts and solvates, which are inhibitors of ssao activity. The compounds inhibit ssao activity..
07/24/14
20140206647
new patent Pyrimidinecarboxamides as cxcr2 modulators
There is disclosed pyridine- and pyrimidinecarboxamide compounds useful as pharmaceutical agents, synthesis processes, and pharmaceutical compositions which include pyridine- and pyrimidinecarboxamides compounds. More specifically, there is disclosed a genus of cxcr2 inhibitor compounds that are useful for treating a variety of inflammatory and neoplastic disorders..
07/24/14
20140206645
new patent Dual action inhibitors against histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme a reductase
Disclosed herein are novel compounds of formula (i), and uses thereof. The compounds of formula (i) are inhibitors of histone deacetylases (hdacs) and 3-hydroxy-3-methylglutaryl coenzyme a (hmg-coa) reductase (hmgr).
07/24/14
20140206637
new patent Inhibition of nonsense mediated mrna decay by drugs that prevent hypusination of eukaryotic initiation factor 5a
Provided are methods for treating a nad comprising administering to a patient suffering from a nad an inhibitor of nmd and a nonsense suppressor, whereby degradation of nmd susceptible mrna is decreased and translation termination at a misplaced nonsense codon is blocked.. .
07/24/14
20140206629
new patent Stromal derived factor inhibition and cxcr4 blockade
The invention relates to inhibition of sdf-1α expression in subacromial bursa cells by cxcr-4 inhibitors. Bursal cell migration in response to sdf-α stimulation is also decreased in the presence of cxcr4 inhibitors.
07/24/14
20140206625
new patent Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions
Dopamine reuptake inhibitors, and their analogs, are disclosed for treating and delaying the progression of autoimmune diseases.. .
07/24/14
20140206622
new patent Stable peptide-based pace4 inhibitors
It is provided pace4 inhibitors and their uses for treating infection, cancer. Particularly, it is provided a method or use for the treatment of a cancer in a subject, comprising administering to the subject a therapeutically effective amount of the pace4 inhibitors or the composition disclosed..
07/24/14
20140206618
new patent Inhibitors of the renal outer medullary potassium channel
The present invention provides compounds of formula ia and the pharmaceutically acceptable salts thereof, which are inhibitors of the romk (kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and conditions associated with excessive salt and water retention..
07/24/14
20140206605
new patent Crystal forms of a hcv protease inhibitor
The present invention relates to different forms of a hcv inhibitory compound.. .
07/24/14
20140206604
new patent 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
The variables are defined herein. Certain compounds of formula i are useful as antiviral agents.
07/24/14
20140206602
new patent Bipartite inhibitors of bacterial rna polymerase
The invention provides bipartite inhibitors of bacterial rna polymerase having the general structural formula (i): x-α-y (i) wherein x is an moiety that binds to the rifamycin binding site of a bacterial rna polymerase, y is a moiety that binds to the ge23077 binding site of a bacterial rna polymerase, and is a linker. The invention also provides compositions comprising such compounds, methods of making such compounds, and methods of using said compounds.
07/24/14
20140206597
new patent Opioid prodrugs with heterocyclic linkers
The embodiments provide prodrug compounds of formulae i-xv. The present disclosure also provides compositions, and their methods of use, where the compositions comprise a prodrug compound of formulae i-xv that provides controlled release of an opioid.
07/24/14
20140206590
new patent Paint stripping compositions
An environmental safety paint stripping composition comprising dichloroethylene, aromatic alcohols and ethers, surfactants, corrosion inhibitors, thickeners, wax solvents and water. This paint stripping composition is particularly useful in stripping paint and other polymeric coatings from metal substrates such as aluminum and it alloys..
07/24/14
20140206588
new patent Antioxidants for post-cmp cleaning formulations
An cleaning composition and process for cleaning post-chemical mechanical polishing (cmp) residue and contaminants from a microelectronic device having said residue and contaminants thereon. The cleaning compositions include novel corrosion inhibitors.
07/24/14
20140206572
new patent Ovarian markers of follicular maturity and uses thereof
The present invention relates to field of fertility. The invention identifies biological ovarian markers from follicular cells, from follicular fluid, from cumulus cells and from oocytes which are indicative of follicular maturity in mammals.
07/24/14
20140206083
new patent Human pluripotent stem cells induced from undifferentiated stem cells derived from a human postnatal tissue
Establishment of human pluripotent stem cells having properties close to human es cells with the genome of the patient per se that can circumvent immunological rejection of transplanted cells from cells derived from a postnatal human tissue are described. Human pluripotent stem cells can be induced by introducing three genes of oct3/4, sox2 and klf 4, or three genes of oct3/4, sox2 and klf 4 plus the c-myc gene or a histone deacetylase (hdac) inhibitor of undifferentiated stem cells present in various human postnatal tissues in which each gene of tert, nanog, oct3/4 and sox2 has not undergone epigenetic inactivation..
07/24/14
20140206061
new patent Bioactive carbon nanotube composite functionalized with b-sheet polypeptide block copolymer, and preparation method thereof
The present invention relates to a bioactive carbon nanotube composite functionalized with a β-sheet polypeptide block copolymer by combination self-assembly, which shows excellent water dispersion, and has biological activity so as to be used as stimulus-responsive and adaptable biomaterials or in the manufacture of cnt-based electronic biosensor devices. In addition, the bioactive carbon nanotube composite can be used as a composition for delivery of a biological active material into cells.
07/24/14
20140205871
new patent Nonaqueous electrolyte secondary battery
A nonaqueous electrolyte secondary battery includes: an electrode assembly including positive and negative electrode plates; a nonaqueous electrolyte; an outer body; and a current interruption mechanism being provided on at least one of a conductive pathway between the positive electrode plate and a positive electrode external terminal and a conductive pathway between the negative electrode plate and a negative electrode external terminal. The nonaqueous electrolyte contains an overcharge inhibitor.
07/24/14
20140205686
new patent Inhibitors of extracellular proteases
Provided is a plant derived extract including inhibitory activity against one or more extracellular proteases which degrade human tissue matrix. Moreover, the amount of inhibitory activity in an extract can be increased by stressing the plant prior to forming an extract.
07/24/14
20140205684
new patent Macrophage inhibitory cytokine-1 (mic-1) as a prognostic marker in chronic kidney disease
The present invention relates to methods of prognosing the survival of a diseased subject, particularly a subject with chronic kidney disease (ckd), as well as selecting an end-stage renal disease subject for a kidney transplant. The methods involve detecting an elevated amount of macrophage inhibitory cytokine-1 (mic-1) in a test body sample from the diseased subject.
07/24/14
20140205670
new patent Stable solid preparations
It is intended to provide a process for producing unstable amorphous benzimidazole compounds having a proton pump inhibitor function, and stable solid preparations for medicinal use containing these compounds which are produced by blending such an amorphous benzimidazole compound with a nontoxic base such as a basic inorganic salt, forming an intermediate coating layer on the layer containing the active ingredient and further forming an enteric coating layer or a release-controlling coating layer.. .
07/24/14
20140205666
new patent Iminosugar in crystalline form
Iminosugar, which possesses known activity as a glycosyltransferase inhibitor, and is used, for example, in the treatment of gaucher's disease, in crystalline form, a process for its preparation and a pharmaceutical composition thereof.. .
07/24/14
20140205663
new patent Direct compression formulation and process
Dipeptidylpeptidase iv inhibitor (herein referred to as dpp-iv) that may be 98.5-100% pure is a high-dose drug capable of direct compressed with specific excipients into sold form dosage forms, such as tablets and capsules having desired, hardness, disintegrating ability and acceptable dissolution characteristics. Dpp-iv is not inherently compressible and thus present formulation problems.
07/24/14
20140205600
new patent Methods of promoting fat loss comprising administering an alk7 inhibitor
The invention relates to alk7 soluble receptors and their uses as antagonists of the function of certain ligands such as gdf-8 (myostatin) and gdf-11. The alk7 soluble receptor of the invention is useful as antagonists of gdf-8 and gdf-11 in the treatment of neuronal diseases or conditions such as stroke, spinal cord injury, and all peripheral nerve diseases.
07/24/14
20140205598
new patent Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation
In one aspect, the invention provides methods of inhibiting the effects of masp-2-dependent complement activation in a living subject. In one embodiment, the invention provides methods of treating a subject suffering from a complement mediated coagulation disorder, such as disseminated intravascular coagulation.
07/24/14
20140205594
new patent Treatment of cancer
Provided are methods relating to compositions that include a cdp-topoisomerase inhibitor, e.g., a cdp-camptothecin or camptothecin derivative conjugate, e.g., crlx101.. .
07/24/14
20140205592
new patent Stratification of cancer patients for susceptibility to therapy with ptk2 inhibitors
The present invention relates to a method for determining whether a cancer patient is susceptible to treatment with a protein tyrosine kinase 2 (ptk2) inhibitor, comprising detecting the expression of the e-cadherin protein in a cancer sample of said cancer patient, wherein an e-cadherin protein immunoreactivity score (irs) of 0-2 indicates that the cancer patient is susceptible to treatment with a ptk2 inhibitor. Said detection of the expression of the e-cadherin protein in a cancer sample of a cancer patient is preferably conducted by way of an immunohistochemistry (ihc) method.
07/24/14
20140205567
new patent Macrocyclic heterocyclic compound for inhibiting hepatitis c virus and preparation and use thereof
The present invention discloses a class of novel macro-heterocyclic compounds represented by the formula ia or ib, and their intermediates, preparation methods and the uses. The macro-heterocyclic compounds of the present invention have good inhibitory activities against hepatitis c virus (hcv), and can be used to treat hcv infection effectively by its excellent inhibition against hcv, low toxicity and side effects..
07/24/14
20140205564
new patent Hepatitis c virus inhibitors
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis c virus (hcv) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of hcv infection..
07/24/14
20140205537
new patent Lrrk2 inhibitors
Provided herein are compounds that inhibit or partially inhibit the activity of leucine rich repeat kinases. Also provided herein are methods of treatment of cns disorders comprising administration of inhibitors of leucine rich repeat kinases..
07/24/14
20140205496
new patent Corrosion inhibiting vapor for use in connection with encased articles
A volatile corrosion inhibiting agent is provided for dispersion of a vapor phase corrosion inhibitor in a vapor stream that is passed into a sheath or other casing enclosing a metal bar, cable, or other tension member to protect said tension member from corrosion.. .


Popular terms: [SEARCH]

Inhibitor topics: Atherosclerosis, Computer Program, Circulation, Fluidically, Hypertension, Nucleic Acid, Oxidative Stress, Pyrrolidine, Hepatitis C, Hepatitis C Virus, Methyl Ester, Crystallin, Antagonist, Immunogenic, Polypeptide

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Inhibitor for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Inhibitor with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.4824

4033

3 - 0 - 86